<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03101163</url>
  </required_header>
  <id_info>
    <org_study_id>KLSMC-003</org_study_id>
    <nct_id>NCT03101163</nct_id>
  </id_info>
  <brief_title>Efficacy and Safety Study of Intra-Articular Injections of Autologous Peripheral Blood Stem Cells Following Subchondral Drilling Surgery for the Treatment of Articular Cartilage Injury in the Knee</brief_title>
  <official_title>Multicenter, Randomized, Open-Label, Standard Treatment-Controlled Parallel Group Phase 2 Study to Evaluate Efficacy and Safety of Intra-Articular Injections of Autologous Peripheral Blood Stem Cells and Hyaluronic Acid Adjuvant Therapy Following Subchondral Drilling Surgery for the Treatment of Articular Cartilage Injury in the Knee With an Optional Open-Label Extension for the Standard Treatment-Controlled Group</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>KLSMC Stem Cells, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>KLSMC Stem Cells, Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a 24-month, multicenter, randomized, open-label, standard treatment-controlled,&#xD;
      parallel-group, Phase 2 study for adults with large or complicated knee articular cartilage&#xD;
      lesions and are candidates for knee joint cartilage repair surgery. The safety and efficacy&#xD;
      of intra-articular injections of peripheral blood stem cells (PBSCs) together with hyaluronic&#xD;
      acid (HA) after subchondral drilling surgery will be evaluated to determine whether PBSC&#xD;
      therapy can improve functional outcome and reduce pain of the knee joint better than a&#xD;
      standard treatment (HA injections and physiotherapy regimen).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a 24-month, multicenter, randomized, open-label, standard treatment-controlled,&#xD;
      parallel-group, Phase 2 study for adults with large or complicated knee articular cartilage&#xD;
      lesions and are candidates for knee joint cartilage repair surgery. The safety and efficacy&#xD;
      of intra-articular injections of peripheral blood stem cells (PBSCs) together with hyaluronic&#xD;
      acid (HA) after subchondral drilling surgery will be evaluated to determine whether PBSC&#xD;
      therapy can improve functional outcome and reduce pain of the knee joint better than a&#xD;
      standard treatment (HA injections and physiotherapy regimen).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">December 2015</start_date>
  <completion_date type="Anticipated">November 2021</completion_date>
  <primary_completion_date type="Anticipated">November 2021</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>International Knee Documentation Committee (IKDC) score</measure>
    <time_frame>24 months</time_frame>
    <description>Subjective IKDC core as a measure of joint function</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Knee injury and Osteoarthritis Outcome (KOOS) pain subdomain</measure>
    <time_frame>24 months</time_frame>
    <description>KOOS pain subdomain score as a measure of joint pain</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Numeric Rating Scale (NRS) for pain</measure>
    <time_frame>24 months</time_frame>
    <description>Numeric Rating Scale (NRS) for pain</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Incidence of Treatment-Emergent Adverse Events [Safety and Tolerability]</measure>
    <time_frame>up to 24 months</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Articular Cartilage Disorder of Knee</condition>
  <condition>Articular Cartilage; Degeneration</condition>
  <arm_group>
    <arm_group_label>Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects randomized to the intervention group will undergo subchondral drilling surgery according to standard protocol, and will also receive a regimen of PBSC and HA intra-articular injections and postoperative physiotherapy.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard treatment</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects randomized to the standard treatment-controlled parallel group will receive intra-articular HA injections and a physiotherapy regimen.</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Autologous peripheral blood stem cells and hyaluronic acid</intervention_name>
    <description>Regimen of intra-articular PBSC and HA injections and postoperative physiotherapy</description>
    <arm_group_label>Intervention</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Hyaluronic acid</intervention_name>
    <description>Regimen of intra-articular HA injections and postoperative physiotherapy</description>
    <arm_group_label>Standard treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Aged between 18 to 55 years at screening (20 to 57 years for the open-label extension)&#xD;
&#xD;
          -  Present for evaluation and treatment of knee pain, knee swelling, or knee mechanical&#xD;
             symptoms due to cartilage lesions&#xD;
&#xD;
          -  Provide written informed consent&#xD;
&#xD;
          -  International Cartilage Repair Society (ICRS) Grade 3 or 4 lesions diagnosis from MRI&#xD;
             scans of the target knee&#xD;
&#xD;
          -  All subjects must also satisfy at least 1 of the following inclusion criteria:&#xD;
&#xD;
               -  Isolated knee articular cartilage lesion (single lesion) estimated to be ≥3 cm2&#xD;
                  as demonstrated on MRI scanning. Multiple knee articular cartilage lesions&#xD;
                  (multiple lesions) with at least 1 lesion estimated to be ≥3 cm2 as demonstrated&#xD;
                  on MRI scanning. Bipolar cartilage defects demonstrated on MRI scanning with at&#xD;
                  least 1 articular surface lesion to be ≥3 cm2. One or more cartilage defects&#xD;
                  involving the patello-femoral joint as demonstrated on MRI scanning with at least&#xD;
                  1 lesion ≥3 cm2. One or more cartilage defects involving the tibio-femoral joint&#xD;
                  as demonstrated on MRI scanning with at least 1 lesion to be ≥3 cm2. Previously&#xD;
                  failed cartilage repair procedures (i.e., microfracture, osteochondral autograft&#xD;
                  transplantation surgery (OATS), ACI)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Three or more previous surgical interventions on the knee in question.&#xD;
&#xD;
          -  Preoperative flexion deformity greater than 10 degrees.&#xD;
&#xD;
          -  Presence of ligamentous injury which would require reconstruction, varus or valgus&#xD;
             deformity requiring osteotomy, or cases that require complex surgery prior to&#xD;
             cartilage regeneration&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Andrews Research &amp; Education Foundation (AREF)</name>
      <address>
        <city>Gulf Breeze</city>
        <state>Florida</state>
        <zip>32561</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kuala Lumpur Sports Medicine Centre</name>
      <address>
        <city>Kuala Lumpur</city>
        <country>Malaysia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Malaysia</country>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>March 24, 2017</study_first_submitted>
  <study_first_submitted_qc>April 3, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 4, 2017</study_first_posted>
  <last_update_submitted>August 30, 2021</last_update_submitted>
  <last_update_submitted_qc>August 30, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 31, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cartilage Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyaluronic Acid</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

